PMID- 21189108
OWN - NLM
STAT- MEDLINE
DCOM- 20110527
LR  - 20131121
IS  - 1440-1665 (Electronic)
IS  - 1039-8562 (Linking)
VI  - 19
IP  - 1
DP  - 2011 Feb
TI  - Pharmacological treatment of behavioural and psychological symptoms of dementia 
      in psychogeriatric inpatient units.
PG  - 59-63
LID - 10.3109/10398562.2010.539611 [doi]
AB  - OBJECTIVE: This study involved an examination of the current patterns of 
      pharmacological treatment of patients with behavioural and psychological symptoms 
      of dementia (BPSD) in psychogeriatric inpatient units. METHOD: An audit was 
      conducted of discharge medications of patients with BPSD who were hospitalized at 
      three separate inpatient units in Perth, Western Australia over a 1-year period. 
      RESULTS: Prescribing patterns were found to be relatively similar across the 
      three units. Dementia-specific drugs such as choline-esterase inhibitors and 
      memantine comprised a minority of prescribed medication. Antipsychotics, 
      benzodiazepines and sodium valproate were the most commonly prescribed drugs. 
      Cyproterone acetate was used in a small number of patients at each of the three 
      units. CONCLUSIONS: The broad range of medications used to treat BPSD, the 
      relatively modest place of dementia-specific drugs in this patient group, and the 
      co-prescribing of more than one psychotropic agent in the majority of patients 
      support the prevailing impressions that BPSD are difficult to treat and that 
      there is no consistently effective or superior medication or drug group.
FAU - Restifo, Sam
AU  - Restifo S
AD  - North Metropolitan Area Older Adult Mental Health Service, Perth, WA, Australia. 
      sam.restifo@health.wa.gov.au
FAU - Lemon, Vivienne
AU  - Lemon V
FAU - Waters, Flavie
AU  - Waters F
LA  - eng
PT  - Journal Article
DEP - 20101229
PL  - England
TA  - Australas Psychiatry
JT  - Australasian psychiatry : bulletin of Royal Australian and New Zealand College of 
      Psychiatrists
JID - 9613603
RN  - 0 (Androgen Antagonists)
RN  - 0 (Antipsychotic Agents)
RN  - 0 (Cholinesterase Inhibitors)
RN  - 0 (Hypnotics and Sedatives)
RN  - 0 (Psychotropic Drugs)
RN  - 614OI1Z5WI (Valproic Acid)
RN  - E61Q31EK2F (Cyproterone)
SB  - IM
MH  - Aged
MH  - Alzheimer Disease/complications/drug therapy/psychology
MH  - Androgen Antagonists/therapeutic use
MH  - Antipsychotic Agents/therapeutic use
MH  - Cholinesterase Inhibitors/therapeutic use
MH  - Cyproterone/therapeutic use
MH  - Dementia/complications/*drug therapy/*psychology
MH  - Dementia, Vascular/complications/drug therapy/psychology
MH  - Drug Prescriptions/statistics & numerical data
MH  - Female
MH  - Geriatric Psychiatry
MH  - Health Services for the Aged
MH  - Hospital Units
MH  - Humans
MH  - Hypnotics and Sedatives/therapeutic use
MH  - Informed Consent
MH  - Male
MH  - Medical Audit
MH  - Mental Disorders/*drug therapy/etiology/*psychology
MH  - Middle Aged
MH  - Psychiatric Department, Hospital
MH  - Psychotropic Drugs/*therapeutic use
MH  - Valproic Acid/therapeutic use
MH  - Western Australia
EDAT- 2010/12/30 06:00
MHDA- 2011/05/28 06:00
CRDT- 2010/12/30 06:00
PHST- 2010/12/30 06:00 [entrez]
PHST- 2010/12/30 06:00 [pubmed]
PHST- 2011/05/28 06:00 [medline]
AID - 10.3109/10398562.2010.539611 [doi]
PST - ppublish
SO  - Australas Psychiatry. 2011 Feb;19(1):59-63. doi: 10.3109/10398562.2010.539611. 
      Epub 2010 Dec 29.